Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs.
HIV reservoirs
active targeting
nanomedicine
passive targeting
phagocytosis
viral infection
Journal
Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357
Informations de publication
Date de publication:
29 Jul 2022
29 Jul 2022
Historique:
received:
20
06
2022
revised:
23
07
2022
accepted:
26
07
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
Highly active anti-retroviral therapy (HAART) is prescribed for HIV infection and, to a certain extent, limits the infection's spread. However, it cannot completely eradicate the latent virus in remote and cellular reservoir areas, and due to the complex nature of the infection, the total eradication of HIV is difficult to achieve. Furthermore, monotherapy and multiple therapies are not of much help. Hence, there is a dire need for novel drug delivery strategies that may improve efficacy, decrease side effects, reduce dosing frequency, and improve patient adherence to therapy. Such a novel strategy could help to target the reservoir sites and eradicate HIV from different biological sanctuaries. In the current review, we have described HIV pathogenesis, the mechanism of HIV replication, and different biological reservoir sites to better understand the underlying mechanisms of HIV spread. Further, the review deliberates on the challenges faced by the current conventional drug delivery systems and introduces some novel drug delivery strategies that have been explored to overcome conventional drug delivery limitations. In addition, the review also summarizes several nanotechnology-based approaches that are being explored to resolve the challenges of HIV treatment by the virtue of delivering a variety of anti-HIV agents, either as combination therapies or by actively targeting HIV reservoir sites.
Identifiants
pubmed: 35956604
pii: polym14153090
doi: 10.3390/polym14153090
pmc: PMC9370744
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Mol Biomed. 2020;1(1):15
pubmed: 34765998
Biochim Biophys Acta. 2002 Feb 1;1558(2):198-210
pubmed: 11779569
Pharmaceuticals (Basel). 2010 Mar 02;3(3):448-470
pubmed: 27713263
J Food Sci Technol. 2018 Jan;55(1):287-298
pubmed: 29358821
Sex Transm Infect. 1999 Oct;75(5):337-9
pubmed: 10616359
Int J Pharm. 2015 Nov 10;495(1):439-446
pubmed: 26367780
Curr Top Microbiol Immunol. 1989;146:13-25
pubmed: 2659263
Nanotechnology. 2009 Sep 9;20(36):365602
pubmed: 19687560
Expert Rev Clin Immunol. 2006 Jul;2(4):613-26
pubmed: 20477617
Materials (Basel). 2022 Feb 23;15(5):
pubmed: 35268907
Drug Deliv. 2016 Sep;23(7):2581-2586
pubmed: 25996834
Int J Pharm. 2021 Sep 25;607:120986
pubmed: 34389421
Antiviral Res. 2010 May;86(2):227-9
pubmed: 20211651
Molecules. 2020 Nov 16;25(22):
pubmed: 33207753
IUBMB Life. 2004 Oct;56(10):609-14
pubmed: 15814459
Infect Dis Rep. 2013 Jun 06;5(Suppl 1):e5
pubmed: 24470969
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Nov-Dec;2(6):693-702
pubmed: 20860050
Arthritis Rheum. 2009 Jan;60(1):12-21
pubmed: 19116913
Adv Ther (Weinh). 2018 Oct;1(6):
pubmed: 32775613
Cell Mol Life Sci. 2009 Sep;66(17):2873-96
pubmed: 19499185
Biomaterials. 2008 Nov;29(33):4429-38
pubmed: 18760470
Antiviral Res. 2010 Jan;85(1):25-33
pubmed: 20018390
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):478-90
pubmed: 19913579
World J Cardiol. 2010 Mar 26;2(3):53-7
pubmed: 21160756
Nanomedicine (Lond). 2010 Jun;5(4):523-8
pubmed: 20528447
AIDS. 1995 Aug;9(8):833-41
pubmed: 7576316
Lancet HIV. 2017 Aug;4(8):e349-e356
pubmed: 28501495
Pharmazie. 2005 Nov;60(11):840-3
pubmed: 16320946
Science. 1984 Jul 6;225(4657):59-63
pubmed: 6328660
J Med Virol. 1989 Nov;29(3):176-80
pubmed: 2533247
BMJ Open. 2021 Dec 17;11(12):e054021
pubmed: 34921085
J Pharm Sci. 2010 Jun;99(6):2576-81
pubmed: 20091830
Biomolecules. 2021 Sep 30;11(10):
pubmed: 34680070
J Antimicrob Chemother. 2009 Jan;63(1):7-10
pubmed: 18984648
Mol Pharm. 2008 Jul-Aug;5(4):505-15
pubmed: 18672949
Pharm Res. 1995 Jun;12(6):884-8
pubmed: 7667195
Retrovirology. 2010 Sep 26;7:78
pubmed: 20868521
Ann N Y Acad Sci. 2008 Nov;1143:1-20
pubmed: 19076341
Med Hypotheses. 1984 Aug;14(4):423-33
pubmed: 6238227
J Virol. 2012 May;86(9):5244-52
pubmed: 22379078
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):227-35
pubmed: 7859133
Pharm Res. 2007 Nov;24(11):2110-9
pubmed: 17701325
Int J Hyperthermia. 2008 Sep;24(6):475-82
pubmed: 18608573
ACS Cent Sci. 2020 Mar 25;6(3):315-331
pubmed: 32226821
Expert Opin Drug Deliv. 2006 Sep;3(5):613-28
pubmed: 16948557
Curr Drug Deliv. 2016;13(7):1071-1083
pubmed: 26777885
Mater Sci Eng C Mater Biol Appl. 2016 Oct 1;67:522-532
pubmed: 27287151
Immunity. 2012 Sep 21;37(3):377-88
pubmed: 22999944
AAPS PharmSciTech. 2018 Feb;19(2):648-660
pubmed: 28948564
Int J Nanomedicine. 2018 Mar 15;13(T-NANO 2014 Abstracts):97-100
pubmed: 29593405
Nanomedicine (Lond). 2009 Jul;4(5):557-74
pubmed: 19572821
AIDS. 2000 Feb 18;14(3):F25-32
pubmed: 10716495
Adv Drug Deliv Rev. 2001 Dec 31;53(3):307-19
pubmed: 11744174
J Virol. 2001 Sep;75(18):8390-9
pubmed: 11507184
Blood. 2006 Oct 15;108(8):2827-35
pubmed: 16809617
Am J Pathol. 1992 Jan;140(1):15-22
pubmed: 1530997
J Clin Invest. 1986 May;77(5):1712-5
pubmed: 2422213
J Biol Chem. 1992 Jan 25;267(3):1719-26
pubmed: 1730714
Acta Pharm. 2008 Mar;58(1):61-74
pubmed: 18337208
J Pharm Sci. 2011 Aug;100(8):3345-3356
pubmed: 21437910
Pharm Res. 2013 Oct;30(10):2512-22
pubmed: 23314933
J Clin Microbiol. 1998 Aug;36(8):2349-52
pubmed: 9666021
Curr Opin Virol. 2016 Jun;18:50-6
pubmed: 27023283
AIDS Res Hum Retroviruses. 2013 May;29(5):746-54
pubmed: 23289671
Artif Cells Nanomed Biotechnol. 2018;46(sup1):79-90
pubmed: 29231058
J Funct Biomater. 2022 May 23;13(2):
pubmed: 35645272
Biomed Res Int. 2014;2014:363404
pubmed: 24967360
Trends Pharmacol Sci. 2011 Dec;32(12):715-25
pubmed: 21899897
Nat Rev Drug Discov. 2003 Aug;2(8):624-34
pubmed: 12904812
AIDS. 1988 Aug;2(4):299-309
pubmed: 3140835
Bull N Y Acad Med. 1996 Summer;73(1):37-45
pubmed: 8804736
Mol Pharm. 2013 Mar 4;10(3):975-87
pubmed: 23331322
Proc Natl Acad Sci U S A. 2022 Jan 11;119(2):
pubmed: 34987100
AAPS PharmSciTech. 2019 Feb 25;20(3):121
pubmed: 30805893
Annu Rev Immunol. 1999;17:625-56
pubmed: 10358770
Anticancer Res. 2003 May-Jun;23(3A):2071-5
pubmed: 12894580
BioDrugs. 2010 Oct 1;24(5):331-43
pubmed: 20795754
J Korean Med Sci. 2022 Feb 07;37(5):e37
pubmed: 35132843
Nat Rev Immunol. 2014 Feb;14(2):94-108
pubmed: 24445665
Pharm Res. 2008 Oct;25(10):2262-71
pubmed: 18516666
Blood. 2007 Jun 15;109(12):5293-300
pubmed: 17351109
Proc Natl Acad Sci U S A. 2002 May 14;99(10):7015-20
pubmed: 12011460
Int J Pharm. 2017 Apr 15;521(1-2):196-203
pubmed: 28229943
AAPS PharmSciTech. 2021 Jun 7;22(5):171
pubmed: 34100170
Chembiochem. 2010 Jun 14;11(9):1273-9
pubmed: 20455239
J Antimicrob Chemother. 2010 Oct;65(10):2183-7
pubmed: 20729545
Clin Exp Immunol. 1991 Jun;84(3):488-92
pubmed: 2044230
Curr Opin HIV AIDS. 2018 Mar;13(2):137-142
pubmed: 29232209
Ann Neurol. 1986 Mar;19(3):224-38
pubmed: 3963767
Front Microbiol. 2015 Jun 23;6:614
pubmed: 26157430
J Drug Target. 2011 May;19(4):258-69
pubmed: 20604740
Curr Opin HIV AIDS. 2016 Jul;11(4):362-70
pubmed: 27259045
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):417-24
pubmed: 22743598
Curr HIV Res. 2006 Apr;4(2):199-208
pubmed: 16611058
NPJ Vaccines. 2021 Apr 9;6(1):50
pubmed: 33837212
Cell. 2000 Mar 3;100(5):587-97
pubmed: 10721995
AIDS. 1996 Dec;10(14):F51-6
pubmed: 8970677
Int J Pharm. 2008 Feb 12;349(1-2):249-55
pubmed: 17875373
Pediatrics. 2002 Feb;109(2):E25
pubmed: 11826235
Cell. 2008 Aug 22;134(4):577-86
pubmed: 18691745
Adv Drug Deliv Rev. 2001 Mar 23;47(1):55-64
pubmed: 11251245
Eur J Pharm Biopharm. 2008 Nov;70(3):853-60
pubmed: 18657611
HIV Clin Trials. 2006 May-Jun;7(3):142-53
pubmed: 16880170
Cell Microbiol. 2007 Sep;9(9):2095-102
pubmed: 17590164
J Virol. 1997 Aug;71(8):6271-5
pubmed: 9223532
Ann Neurol. 2010 Apr;67(4):526-33
pubmed: 20437588
Nat Immunol. 2002 Oct;3(10):975-83
pubmed: 12352970
Toxicon. 2008 Jul;52(1):13-21
pubmed: 18588907
Eur J Pharm Biopharm. 2007 Aug;67(1):76-85
pubmed: 17303396
Materials (Basel). 2020 Nov 27;13(23):
pubmed: 33260938
Annu Rev Immunol. 2000;18:665-708
pubmed: 10837072
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2307-12
pubmed: 24469825
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006841
pubmed: 22229120
Expert Opin Drug Deliv. 2009 Aug;6(8):771-84
pubmed: 19566446
J Neuroimmune Pharmacol. 2021 Dec;16(4):796-805
pubmed: 34528173
Biochim Biophys Acta. 2007 Apr;1770(4):681-6
pubmed: 17276009
Biomed Res Int. 2014;2014:526391
pubmed: 25057492
Pharmaceutics. 2019 Feb 25;11(2):
pubmed: 30823545
Nanomedicine (Lond). 2017 Dec;12(24):2721-2736
pubmed: 29119867
Artif Cells Nanomed Biotechnol. 2015 Apr;43(2):71-86
pubmed: 24564348
Cancer Res. 2000 Aug 15;60(16):4440-5
pubmed: 10969790
Proc Natl Acad Sci U S A. 1978 Jul;75(7):3400-4
pubmed: 277940
Drugs. 2013 Sep;73(13):1431-50
pubmed: 24002702
Curr Med Chem. 2002 Nov;9(21):1893-903
pubmed: 12369874
Eur J Pharm Biopharm. 2021 Aug;165:41-51
pubmed: 33971273
Infect Dis Ther. 2018 Jun;7(2):183-195
pubmed: 29761330
Int J Nanomedicine. 2010 Aug 09;5:533-47
pubmed: 20957115
J Cytol Mol Biol. 2014 Jan 10;1(1):
pubmed: 24672807
Curr Infect Dis Rep. 2001 Dec;3(6):553-560
pubmed: 11722814
Nanomedicine. 2008 Mar;4(1):41-8
pubmed: 18207463
Can J Infect Dis Med Microbiol. 2005 Jul;16(4):233-43
pubmed: 18159551
J Pain Symptom Manage. 2001 Jan;21(1):41-51
pubmed: 11223313
Eur J Pharm Sci. 2021 Sep 1;164:105916
pubmed: 34166780
J Immunol. 2009 Jul 1;183(1):661-9
pubmed: 19535632
Eur J Pharm Biopharm. 2019 May;138:48-63
pubmed: 29879528
Cancer Res. 2009 Dec 15;69(24):9395-403
pubmed: 19951991
Biomaterials. 2013 Aug;34(26):6202-28
pubmed: 23726227
J Pharm Pharmacol. 2006 May;58(5):605-16
pubmed: 16640829
Acta Naturae. 2016 Oct-Dec;8(4):23-32
pubmed: 28050264
Ther Deliv. 2011 Jan;2(1):25-35
pubmed: 22833923
PLoS One. 2015 Oct 13;10(10):e0140399
pubmed: 26461917
Int J Nanomedicine. 2015 Sep 23;10:5965-79
pubmed: 26445538
J Virol. 2000 Sep;74(18):8550-7
pubmed: 10954556
Clin Microbiol Rev. 2016 Oct;29(4):859-80
pubmed: 27559075
Antioxidants (Basel). 2020 Nov 26;9(12):
pubmed: 33256059
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2769-75
pubmed: 17048481
Colloids Surf B Biointerfaces. 2011 Apr 1;83(2):299-306
pubmed: 21194902
Clin Ther. 2000 Jun;22(6):685-708
pubmed: 10929917
Biochim Biophys Acta. 1994 Feb 23;1190(1):99-107
pubmed: 8110825
World J Gastroenterol. 2018 Nov 14;24(42):4728-4737
pubmed: 30479460
AIDS. 1994 Nov;8(11):1545-53
pubmed: 7848591
J Biol Chem. 2003 Aug 29;278(35):33248-55
pubmed: 12796502
J Leukoc Biol. 2010 Apr;87(4):589-98
pubmed: 19952353
Pharmaceutics. 2018 Dec 11;10(4):
pubmed: 30544966
Annu Rev Med. 2002;53:557-93
pubmed: 11818490
Front Genet. 2020 May 26;11:497
pubmed: 32528527
Int J Pharm. 2014 Feb 28;462(1-2):129-34
pubmed: 24374067
Nano Lett. 2005 Feb;5(2):325-9
pubmed: 15794620
J Drug Target. 2008 Dec;16(10):798-805
pubmed: 19005941
AIDS. 2014 Jan 28;28(3):439-42
pubmed: 24322272
PLoS One. 2009;4(3):e5065
pubmed: 19333384
Small. 2009 Jan;5(1):126-34
pubmed: 19051182
AIDS. 2014 Sep 24;28(15):2175-87
pubmed: 25144219
J Control Release. 2010 Dec 20;148(3):359-67
pubmed: 20854859
Drug Metab Dispos. 1995 Jul;23(7):730-5
pubmed: 7587962
Int J Pharm. 2011 Dec 15;421(2):341-52
pubmed: 21986114
J Control Release. 2021 Feb 10;330:529-539
pubmed: 33358977
J Control Release. 2009 Aug 19;138(1):2-15
pubmed: 19445981
J Control Release. 2007 Aug 16;121(1-2):3-9
pubmed: 17544538
Pharmaceutics. 2022 May 20;14(5):
pubmed: 35631683
Chest Surg Clin N Am. 1999 Feb;9(1):39-61, vii-viii
pubmed: 10079979
Nat Med. 2010 Apr;16(4):446-51
pubmed: 20208541
Lancet. 2006 Aug 5;368(9534):489-504
pubmed: 16890836
Curr Med Chem. 2014;21(36):4186-98
pubmed: 25174930
Lancet. 2005 Mar 19-25;365(9464):1031-8
pubmed: 15781098